![Samuel Jason](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Samuel Jason
Finanzdirektor/CFO bei Astex Pharmaceuticals, Inc.
Aktive Positionen von Samuel Jason
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Astex Pharmaceuticals, Inc.
![]() Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded in March 1991 and is headquartered in Pleasanton, CA. | Finanzdirektor/CFO | 01.01.1998 | - |
Karriereverlauf von Samuel Jason
Ausbildung von Samuel Jason
The California State University | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Director of Finance/CFO | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Astex Pharmaceuticals, Inc.
![]() Astex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Astex Pharmaceuticals, Inc. researches and develops oncology drugs. It is dedicated to the discovery, development, and commercialization of novel therapeutics with a focus on cancer. Its products include Guadecitabine, Onalespib, AT7519, AT13148, ASTX727, ASTX660. The company was founded in March 1991 and is headquartered in Pleasanton, CA. | Health Technology |
- Börse
- Insiders
- Samuel Jason
- Erfahrung